TTNP News and Press, Titan Pharmaceuticals Inc. From 06/10/22

NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) -- David E. Lazar, Chief Executive Officer of Activist Investing LLC (together with its affiliates, “Activist Investing” or “we”), one of the largest stockholders of Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“TTNP...

NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Activist Investing LLC (together with its affiliates, “Activist Investing” or “we”), today filed a Schedule 13D announcing its acquisition of approximately 5.6% of the common stock outstanding of Titan Pharmaceuticals,...

Titan Pharmaceuticals (NASDAQ:TTNP) trades 3.9% lower premarket after it entered into a securities purchase agreement with a single institutional investor to purchase 3.37M shares in a registered direct offering priced at-the-market. In a concurrent private placement, Titan has...

Titan Pharmaceuticals Announces Pricing of $5.5 Million Registered Direct and PIPE Offering Priced At-The-Market PR Newswire SOUTH SAN FRANCISCO, Calif. , Feb. 2, 2022 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") toda...

Titan Pharmaceuticals (NASDAQ:TTNP) has gained ~15.0% in the pre-market after announcing it has started a process to evaluate strategic alternatives to improve shareholder value. The pharmaceutical developer has selected Maxim Group LLC as its exclusive advisor to assist it in this ...

Reliance Global (NASDAQ:RELI) +85%. Aridis Pharmaceuticals (NASDAQ:ARDS) +72% after its antibody cocktail retains effectiveness against Omicron variant. Quoin Pharmaceuticals (NASDAQ:QNRX) +44%. Cassava Sciences (NASDAQ:SAVA) +40% Cassava Sciences, Biofrontera rise amid so...

Titan Pharmaceuticals to Explore Strategic Alternatives PR Newswire SOUTH SAN FRANCISCO, Calif. , Dec. 21, 2021 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has commenced a process to explore a...

Sustained Anti-Pruritic Effect Of Titan's TP-2021 Implant Reported Today At Neuroscience 2021 PR Newswire SOUTH SAN FRANCISCO, Calif. , Nov. 8, 2021 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced that, in a present...

Titan Announces Upcoming TP-2021 Implant Data Presentation at Neuroscience 2021 PR Newswire SOUTH SAN FRANCISCO, Calif. , Nov. 5, 2021 /PRNewswire/ -- Titan Pharmaceuticals, Inc. announced that data from continuing studies of its ProNeura ® -based TP-202...

Remark Holdings (NASDAQ:MARK) +266%. Sonim Technologies (NASDAQ:SONM) +96%. Creatd (NASDAQ:CRTD) +69% announces second NFT drop, includes photographs of former President Donald Trump PAE Incorporated (NASDAQ:PAE) +67% Amentum to buy PAE in an all-cash deal valued at ~$1.9 ...